INNOVENT BIOLOGICS INC. (IVBXF)
Clinical trial NCT05460767 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2024-12-31 → 2027-06-30 3. primary completion date: 2024-03-31 → 2026-12-31 4. enrollment: 260 → 504 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical